MBD2a–NuRD binds to the methylated γ-globin gene promoter and uniquely forms a complex required for silencing of HbF expression is a research paper published in Proceedings of the National Academy of Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 49 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | National Institutes of Health
Grant: R01DK115563
HHS | NIH | Office of Extramural Research, National Institutes of Health
Grant: P30CA016086
NCI NIH HHS
Grant: P30 CA016059
National Institutes of Health
Grant: 3P30CA016086-42S2
Cancer Center Support Grant
National Institutes of Health
Grant: 4P30CA016059-35
Massey Cancer Center Support Grant
National Institutes of Health
Grant: 5R01DK115563-02
The role of the MBD2-NuRD complex in gamma-globin gene silencing
FWCI
9.15
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
Additional file 1 of Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
Additional file 2 of Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
Additional file 2 of Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
Additional file 3 of Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
Additional file 3 of Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
Additional file 4 of Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
Additional file 4 of Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
Additional file 5 of Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
Additional file 5 of Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
Additional file 3 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
Additional file 1 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
Additional file 6 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
Additional file 8 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
Additional file 5 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
Additional file 3 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
Additional file 1 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
Additional file 5 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
Additional file 7 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
Additional file 9 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5